Results 231 to 240 of about 19,152,238 (244)

4-(1,3-Thiazol-2-yl)morpholine derivatives as inhibitors of phosphoinositide 3-kinase

Bioorganic and Medicinal Chemistry Letters, 2008
Prakash Mistry
exaly  

Discovery of new thienopyrimidine derivatives as potent and orally efficacious phosphoinositide 3-kinase inhibitors

Bioorganic and Medicinal Chemistry, 2018
Yi Dong, Heng Xu, Yang Yakun
exaly  

Discovery of 4-morpholino-pyrimidin-6-one and 4-morpholino-pyrimidin-2-one-containing Phosphoinositide 3-kinase (PI3K) p110β isoform inhibitors through structure-based fragment optimisation

Bioorganic and Medicinal Chemistry Letters, 2012
Fabrizio Giordanetto
exaly  

Angiogenesis Inhibitors: Current Strategies and Future Prospects†‡

Ca-A Cancer Journal for Clinicians, 2010
Kristina M Cook, W D Figg
exaly  

Development of Phosphoinositide-3 Kinase Pathway Inhibitors for Advanced Cancer

Current Oncology Reports, 2010
James M Cleary, Geoffrey I Shapiro
exaly  

Rational Design of Phosphoinositide 3-Kinase α Inhibitors That Exhibit Selectivity over the Phosphoinositide 3-Kinase β Isoform

Journal of Medicinal Chemistry, 2011
Steven T Staben, Paul Goldsmith, Christian Wiesmann   +2 more
exaly  

Journal of Enzyme Inhibition and Medicinal Chemistry

Journal of Enzyme Inhibition and Medicinal Chemistry, 2023
exaly  

Mechanism of Protein Kinase B Activation by Insulin/Insulin-Like Growth Factor-1 Revealed by Specific Inhibitors of Phosphoinositide 3-Kinase—Significance for Diabetes and Cancer

Pharmacology & Therapeutics, 1999
Jongsun Park, Mirjana Andjelković, M Andjelković   +2 more
exaly  

Editorial [Hot Topic: Phosphoinositide 3-Kinase Pathway Inhibitors: Pharmacology, Metabolism & Drug Development (Guest Editor: Marco Falasca)]

Current Medicinal Chemistry, 2011
Marco Falasca
exaly  

Discovery of nanomolar phosphoinositide 3-kinase gamma (PI3Kγ) inhibitors using ligand-based modeling and virtual screening followed by analysis

European Journal of Medicinal Chemistry, 2014
Mahmoud A Al-Sha'er, Mohammad Khanfar, Mutasem O. Taha   +2 more
exaly